Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
61 items

NEI posts executive summary of workshop on extracellular vesicles

The September 14 workshop brought together multidisciplinary experts in extracellular vesicles – cell-secreted nanoparticles that mediate cell-cell communication.

Short-term use of immunosuppressants not linked to cancer risk

Relatively short-term use of immunosuppressant medications to control an inflammatory disease was not associated with an increased risk of later developing cancer, according to new research.
Researchers in the laboratory.

Herpes study adds to understanding of viral reinfections, how to potentially prevent them

A new study on herpes infections of the eye from University of Illinois Chicago researchers identifies a key protein involved in viral reinfections that could be targeted by antiviral drugs.

Powerful enzyme that tamps down inflammation holds promise for protecting eyes in diabetes, premature birth

An enzyme under study to treat certain cancers is also showing promise in reducing the significant vision damage that can result from diabetes and premature birth, scientists report.

Noninvasive technique collects sufficient tear fluid to look for biomarkers of health and disease

Scientists from Augusta University have fine-tuned a non-invasive and efficient way to evaluate the tear film for clues about wellness and disease.
Green iris

Report on anterior segment inflammation and immunity posted

Part of the Anterior Segment Initiative, the meeting addressed gaps in knowledge, barriers to new therapies, and promising areas for research.
Phoebe Lin, MD, PhD

Pathway to better eye health runs through the gut

Ocular inflammation research from OHSU targets gastrointestinal microbes.

Reimagining immunity in the eye

In a new study, the researchers show that immune cells respond to the lens, not just following an acute injury in the eye, but also to long-lasting inflammation.
Mouse retina

NIH scientists discover new B cell that tempers autoimmunity

Findings in mice point to potential therapies for blinding eye disease uveitis and multiple sclerosis

Small amounts of carbon monoxide may help protect vision in diabetes

The Medical College of Georgia scientists have early evidence that HBI-002, a low-dose oral compound, can safely reduce oxidative stress and inflammation in the retina, both early, major contributors to diabetic retinopathy.